Skip to content

To compare outcomes between a standard protocol and a luteal phase estradiol in infertile patients with poor responders

To compare outcomes between a standard protocol and a luteal phase estradiol in infertile patients with poor responders

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138901311760N4
Enrollment
60
Registered
2011-01-06
Start date
2010-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

poor responder patients in ART(Assisted Reproductive Technology). Other ovarian dysfunction

Interventions

Intervention 1: Group 1: oral contraceptive LD
GnRH agonist injection
Gonadotropin injection
HCG injection (10000 IU Im). Intervention 2: Group2: Oral contraceptive LD
CnRH agonists injection
Oral estradiol 2mg, twice a day
HCG injection (10000 Iu Im).
Treatment - Drugs
Group 1: oral contraceptive LD
HCG injection (10000 IU Im)
Group2: Oral contraceptive LD
HCG injection (10000 Iu Im)

Sponsors

Vice Chancellor for Research and Technology, Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
37 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Infertile patents with poor ovarian response, Oocytes number37, Basal FSH>12 Or canceled the previous cycle. Exclusion criteria: Patients who do not consent to enter the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Number of oocytes. Timepoint: puncher day. Method of measurement: Counted by the laboratory.;Total fetus. Timepoint: 2 days after puncher. Method of measurement: Counted by the laboratory.

Secondary

MeasureTime frame
Pregnancy. Timepoint: 17 days after embryo transfer. Method of measurement: blood BHCG test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNargess Gholizadeh Pasha

Fatemehzahra Fertility & reproductive Health Reseach Center

zahra@mubabol.ac.ir , ngh_pa@yahoo.com+98 11 1227 4881

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026